DAFTAR PUSTAKA

1. Infodatin, 2018, Pusat Data Dan Informasi Kementerian Kesehatan RI, Kementerian
Kesehatan RI, 2019.
2. WHO. 2018 Global report on diabetes. Publications of the World Health
Organization are available on the WHO website (http://www.who.int).
3. American Diabetes Association, Standards of Medical Care in Diabetes 2016 in
Diabetes Care, vol.39 (Suppl 1, 2016), s8-12, s20-22.
4. PERKENI, Konsensus Pengendalian dan Pencegahan DM tipe 2 di Indonesia,
2015;1-78.
5. Nouvong A, Armstrong DG. Diabetic Foot Ulcers. In: Cronenwett JL, Johnston KW,
editors. Rutherford’s Vascular Surgery. 8th ed. Philadelphia: Elsevier Saunders; 2014.
6. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al.
Diabetic foot disorders: A clinical practice guideline (2006 revision). J Foot Ankle
Surg. 2006;45:1-66.
7. Riset Kesehatan Dasar. (RISKESDAS). 2013. Jakarta: Badan Penelitian dan
Pengembangan Kesehatan, 
 Kementerian Kesehatan Republik Indonesia: 2014.
8. Kessler L, Bilbault P, Ortega F, Grasso C, Passemard R, Stephan D, et al. Hyperbaric
Oxygenation Accelerates the Healing Rate of Nonischemic Chronic Diabetic Foot
Ulcers: A prospective randomized study. Diabetes Care. 2003 Aug 1;26(8):2378–82.
9. Flood MS. Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers. The Journal of
Lancaster General Hospita. 2(4):141–5.
10. Vishwanath G, Bhutani S. Hyperbaric oxygen and wound healing. Indian Journal of
Plastic Surgery. 2012;45(2):316.
11. Sahni T, Hukku S, Jain M, Prasad A, Prasad R, Singh K. Recent Advances in
Hyperbaric Oxygen Therapy. Venkatraman MGS, editor. Medicine Update.
2004;14:632–9.
12. Tulong M, Hatibie M, Oley MC. Pola penggunaan terapi hiperbarik di RSUP Prof.
Dr. R. D. Kandou Manado periode tahun 2013- 2016. 2016;4:5.
13. Purnamasari D. Diagnosis dan Klasifikasi Diabetes Melitus. In: Buku Ajar Ilmu
Penyakit Dalam. 6th ed. Jakarta: Interna Publishing; 2014.

38
14. Song F, Jia W, Yao Y, Hu Y, Lei L et al. 2007. Oxidative stress, antioxidant status
and DNA damage in patients with impaired glucose regulation and newly diagnosed
Type 2 diabetes, Clinical Science 112, 599-606.
15. Suryohudoyo P. 2007., Dasar Molekuler Diabetes Mellitus. Kapita Selekta Ilmu
Kedokteran Molekuler. Sagung Seto. Jakarta. 48-57.
16. Gu H.F, Ma J, Gu K.T.and Brismar K. (2013). Association of intercellular
adhesion molecule1 (ICAM1) with diabetes and diabetic nephropathy,
Frontiers in endokrinology 179, 1-7.
17. Kaku.(2010). Pathophysiology of Type 2 Diabetes and Its Treatment Policy.
Research and Reviews. Journal of the Japan Medical Association,.53 (1) : 41-
46.
18. Shah SF, Hameed S, Khawaja Z, Abdullah T, Waqar SH, Zahid MA. Evaluation and
Management of Diabetic Foot: A Multicenter study conducted at. :5.
19. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al.
Diagnosis and Treatment of Diabetic Foot Infections: Plastic and Reconstructive
Surgery. 2006 Jun;117(SUPPLEMENT):212S-238S.
20. Boulton A. The diabetic foot: from art to science. The 18th Camillo Golgi lecture.
Diabetologia. 2004;47(8):1343–53.
21. Clayton W, Elasy TA. A Review of the Pathophysiology, Classification, and
Treatment of Foot Ulcers in Diabetic Patients. Clinical Diabetes. 2009 Mar
1;27(2):52–8.
22. Thorne CH. Grabb and Smith’s Plastic Surgery. 7th ed. Philadelphia: Lippincott
Williams
23. Shah SF, Hameed S, Khawaja Z, Abdullah T, Waqar SH, Zahid MA. Evaluation and
Management of Diabetic Foot: A Multicenter study conducted at. :5.
24. Reliability and Validity of the Perfusion, Extent, Depth, Infection and Sensation
(PEDIS) Classification System and Score in Patients with Diabetic Foot Ulcer, PLoS
One, 2015.
25. The International Working Group On The Diabetik Foot. IWGDF Guideline on the
classification of diabetic foot ulcer, Portugal, 2019.
26. Diehm N, Dick F, Czuprin C, Lawall H, Baumgartner I, Diehm C. Oscillometric
measurement of ankle-brachial index in patients with suspected peripheral vascular
disease: comparison with Doppler method. SWISSMEDWKLY. :7.

39
27. Chang C-H, Peng Y-S, Chang C-C, Chen M-Y. Useful screening tools for preventing
foot problems of diabetics in rural areas: a cross-sectional study. BMC Public Health.
2013 Dec;13(1).
28. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M.
Angiogenesis promoted by vascular endothelial growth factor: Regulation through 1 1
and 2 1 integrins. Proceedings of the National Academy of Sciences. 1997 Dec
9;94(25):13612–7.
29. Suzuma K, Takagi H, Otani A, Honda Y. Hypoxia and vascular endothelial growth
factor stimulate angiogenic integrin expression in bovine retinal microvascular
endothelial cells. 1998;39(6):8.
30. Fox A, Smythe J, Fisher N, Tyler MPH, McGrouther DA, Watt SM, et al.
Mobilization of endothelial progenitor cells into the circulation in burned patients.
British Journal of Surgery. 2007 Aug 14;95(2):244–51.
31. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The Role of
Vascular Endothelial Growth Factor in Wound Healing. Journal of Surgical Research.
2009 May;153(2):347–58.
32. Wang H, Keiser JA. Vascular Endothelial Growth Factor Upregulates the Expression
of Matrix Metalloproteinases in Vascular Smooth Muscle Cells : Role of flt-1.
Circulation Research. 1998 Oct 19;83(8):832–40.
33. Centers for Disease Control and Prevention. National diabetes fact sheet: national
estimates and general information on diabetes and prediabetes in the United States,
2011. Atlanta GA: U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention; 2011.
34. Wijelath ES, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z, et
al. Heparin-II Domain of Fibronectin Is a Vascular Endothelial Growth Factor-
Binding Domain: Enhancement of VEGF Biological Activity by a Singular Growth
Factor/Matrix Protein Synergism. Circulation Research. 2006 Oct 13;99(8):853–60.
35. Gottrand, G., Courau, T., Thomas-Vaslin, V., Prevel, N., Vazquez, T.,
Ruocco, M. G., Lambrecht, B., Bellier, B., Colombo, B. M., Klatzmann, D.
(2015) Regulatory T-cell development and function are impaired in mice lacking
membrane expression of full length intercellular adhesion molecule-1. Immunology
146: 657-670.

40
36. Staunton D.E., Dustin M.L., Erickson H.P, and Springer T.A. (1990). The
arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites
for LFA-1 and rhinovirus. Cell 61, 243-254.
37. Witkowska A.M, Barowska M.H. 2004. Soluble intercellular adhesion molecule-
1 (sICAM-1): an overview. Eur-Cytokine Netw., Vol. 15 No 2, 91-98.
38. Lawson C, Wolf S. (2009). ICAM-1 signaling in endothelial cells.
Pharmacological Reports, 61, 22-32.
39. Roy J., Audette M, and Tremblayi M.J . (2001) Intercellular Adhesion Molecule-
1 (ICAM-1) Gene Expression in Human T Cells Is Regulated by
Phosphotyrosyl Phosphatase Activity, Canada, JBC Vol. 276, No. 18, 1-10.
40. Hickey M.J, Kubes P. 2009. Intravascular immunity: the host-pathogen encounter
in blood vessels, Nature Review Immunology, Macmillan Publisher vol 9, 364-375.
41. Rudd, J.H.F, J.R Davies, dan Peter L. Weissberg. 2007. Textbook of
Cardiovascular Medicine, 3rd Edition (eds) dalam E.J Topol. Ohio: Lippincott
Williams & Wilkin.
42. Paneni F, Beckman J.A, Mark A. Creager M.A, and Cosentino F (2013). Diabetes
and vascular disease: pathophysiology, clinical consequences, and medical
therapy: part I, European Heart Journal 34, 2436-2446
43. Ghonaim M.M, El Edel R. H., (2015). Circulating Cell Adhesion Molecules
(sICAM-1 and sVCAM-1) and Microangiopathy in Diabetes Mellitus, Ibnosina J
Med BS, 211-218.
44. Eming SA, Lauer G, Cole M, Jurk S, Christ H, Hornig C, et al. Increased Levels of
the Soluble Variant of the Vascular Endothelial Growth Factor Receptor VEGFR-1
Are Associated with a Poor Prognosis in Wound Healing. Journal of Investigative
Dermatology. 2004 Oct;123(4):799–802.
45. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, et al. Topical
Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through
Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived
Cells. The American Journal of Pathology. 2004 Jun;164(6):1935–47.
46. Zhang J. Growth factors in the pathogenesis of diabetic foot ulcers. Frontiers in
Bioscience. 2018;23(1):310–7.
47. Amali Muhammad A, Fakurazi S, Arulselvan P, See CP, Abas F. Evaluation of
wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on

41
 experimentally induced diabetic animal model. Drug Design, Development and
Therapy. 2016 May;1715.
48. Altavilla D, Bitto A, Polito F, Marini H, Minutoli L, Stefano V, et al.
Polydeoxyribonucleotide (PDRN): A Safe Approach to Induce Therapeutic
Angiogenesis in Peripheral Artery Occlusive Disease and in Diabetic Foot Ulcers.
Cardiovascular & Hematological Agents in Medicinal Chemistry. 2009 Oct
1;7(4):313–21.
49. Zhang Q, Piston DW, Goodman RH. Regulation of Corepressor Function by Nuclear
NADH. 2002;295:4.
50. Dennog C, Radermacher P, Barnett YA, Speit G. Antioxidant status in humans after
exposure to hyperbaric oxygen. Mutation Research/Fundamental and Molecular
Mechanisms of Mutagenesis. 1999 Jul;428(1–2):83–9.
51. Markowicz S, Mehta A. The Effect of Human Dendritic Cells on the Lectin-Induced
Responsiveness of CD4+ T Cells To IL-2 and IL-4. In: Kamperdijk EWA,
Nieuwenhuis P, Hoefsmit ECM, editors. Dendritic Cells in Fundamental and Clinical
Immunology. Boston, MA: Springer US; 1993. p. 75–80.
52. Rothfuss A, Radermacher P, Speit G. Involvement of heme oxygenase-1 (HO-1) in
the adaptive protection of human lymphocytes after hyperbaric oxygen (HBO)
treatment. Carcinogenesis. 2001 Dec;22(12):1979–85.
53. Brennan M-L, Wu W, Fu X, Shen Z, Song W, Frost H, et al. A Tale of Two
Controversies: Defining Both The Role Of Peroxidases in Nitrotyrosine formation In
Vivo Using Eosinophil Peroxidase And Myeloperoxidase-Deficient Mice, And The
Nature Of Peroxidase-Generated Reactive Nitrogen Species. Journal of Biological
Chemistry. 2002 May 17;277(20):17415–27.
54. Lakshmi VM, Nauseef WM, Zenser TV. Myeloperoxidase Potentiates Nitric Oxide-
mediated Nitrosation. Journal of Biological Chemistry. 2005 Jan 21;280(3):1746–53.
55. Demidova-Rice TN, Hamblin MR, Herman IM. Acute and Impaired Wound Healing:
Pathophysiology and Current Methods for Drug Delivery, Part 2: Role of Growth
Factors in Normal and Pathological Wound Healing: Therapeutic Potential and
Methods of Delivery. 2012;25(8):22.
56. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al.
Prediction of outcome in individuals with diabetic foot ulcers: focus on the
differences between individuals with and without peripheral arterial disease. The
EURODIALE Study. Diabetologia. 2008 May;51(5):747–55.

42
57. Senger D, Galli S, Dvorak A, Perruzzi C, Harvey V, Dvorak H. Tumor cells secrete a
vascular permeability factor that promotes accumulation of ascites fluid. Science.
1983 Feb 25;219(4587):983–5.
58. Zhou K, Ma Y, Brogan MS. Chronic and non-healing wounds: The story of vascular
endothelial growth factor. Medical Hypotheses. 2015 Oct;85(4):399–404.
59. Losi P, Briganti E, Errico C, Lisella A, Sanguinetti E, Chiellini F, et al. Fibrin-based
scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound
healing in diabetic mice. Acta Biomaterialia. 2013 Aug;9(8):7814–21.
60. Bao W, Min D, Twigg SM, Shackel NA, Warner FJ, Yue DK, et al. Monocyte CD147
is induced by advanced glycation end products and high glucose concentration:
possible role in diabetic complications. American Journal of Physiology-Cell
Physiology. 2010 Nov;299(5):C1212–9.
61. Wibowo A. Oksigen Hiperbarik: Terapi Percepatan Penyembuhan Luka. :5.
62. Thom SR. Hyperbaric Oxygen: Its Mechanisms and Efficacy: Plastic and
Reconstructive Surgery. 2011 Jan;127:131S-141S.
63. Thom SR. Analytic Reviews : Hyperbaric Oxygen Therapy. Journal of Intensive Care
Medicine. 1989 Mar;4(2):58–74.
64. Kemp M, Go Y-M, Jones DP. Nonequilibrium thermodynamics of thiol/disulfide
redox systems: A perspective on redox systems biology. Free Radical Biology and
Medicine. 2008 Mar;44(6):921–37.
65. Circu ML, Yee Aw T. Glutathione and apoptosis. Free Radical Research. 2008
Jan;42(8):689–706.
66. Rothfuss A, Radermacher P, Speit G. Involvement of heme oxygenase-1 (HO-1) in
the adaptive protection of human lymphocytes after hyperbaric oxygen (HBO)
treatment. Carcinogenesis. 2001 Dec;22(12):1979–85.
67. Brennan M-L, Wu W, Fu X, Shen Z, Song W, Frost H, et al. A Tale of Two
Controversies: Defining Both The Role Of Peroxidases in Nitrotyrosine formation In
Vivo Using Eosinophil Peroxidase And Myeloperoxidase-Deficient Mice, And The
Nature Of Peroxidase-Generated Reactive Nitrogen Species. Journal of Biological
Chemistry. 2002 May 17;277(20):17415–27.
68. Lakshmi VM, Nauseef WM, Zenser TV. Myeloperoxidase Potentiates Nitric Oxide-
mediated Nitrosation. Journal of Biological Chemistry. 2005 Jan 21;280(3):1746–53.

43
69. Sampson JB, Ye Y, Rosen H, Beckman JS. Myeloperoxidase and Horseradish
Peroxidase Catalyze Tyrosine Nitration in Proteins from Nitrite and Hydrogen
Peroxide. Archives of Biochemistry and Biophysics. 1998 Aug;356(2):207–13.
70. Cabigas B, Su J, Hutchins W, Shi Y, Schaefer R, Recinos R, et al. Hyperoxic and
hyperbaric-induced cardioprotection: Role of nitric oxide synthase 3. Cardiovascular
Research. 2006 Oct 1;72(1):143–51.
71. Hink J, Thom SR, Simonsen U, Rubin I, Jansen E. Vascular reactivity and endothelial
NOS activity in rat thoracic aorta during and after hyperbaric oxygen exposure.
American Journal of Physiology-Heart and Circulatory Physiology. 2006
Oct;291(4):H1988–98.
72. Thom SR, Bhopale V, Fisher D, Manevich Y, Huang PL, Buerk DG. Stimulation of
nitric oxide synthase in cerebral cortex due to elevated partial pressures of oxygen:
An oxidative stress response. Journal of Neurobiology. 2002 May;51(2):85–100.
73. Fleiss JL. The Design and Analysis of Clinical Experiments (Appendix: Sample Size
Determination). New York, New York: Wiley; 1986:369-371
74. Borm GF, Fransen J, Lemmens WAJG. A simple sample size formula for analysis of
covariance in ran-domized clinical trials. J Clin Epidemiol 2007;60:1234-1238.
75. Ponthieux A, Herbeth B, Droesch S, Lambert D, Visvikis S. Age- and sex-related
reference values for serum adhesion molecule concentrations in healthy individuals:
intercellular adhesion molecule-1 and E-, P-, and L-selectin. Clin Chem. 2003
Sep;49(9):1544-6.

44